HOWL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 115037 min ago

@ $6.85

Wydano: 9 vas. 2024 @ 17:56

Zwrot: -1.46%

Poprzedni sygnał: vas. 8 - 18:03

Poprzedni sygnał: Sprzedaż

Zwrot: 3.95 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer...

Stats
Dzisiejszy wolumen	82 150.00
Średni wolumen	227 943
Kapitalizacja rynkowa	288.48M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $-0.350 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.43
ATR14	$0.0190 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Atkins Michael B.	Buy	35 000	Stock Option (right to buy)
2024-01-04	Atkins Michael B.	Sell	0	Common Stock
2024-01-02	Trost Timothy W.	Buy	150 000	Stock Option (right to buy)
2024-01-02	Lubman Ellen	Buy	131 900	Stock Option (right to buy)
2024-01-02	Isaacs Randi	Buy	200 000	Stock Option (right to buy)

INSIDER POWER
99.27
Last 97 transactions
Buy: 45 258 272 \| Sell: 143 550 934

Wolumen Korelacja

Długi: 0.24 (neutral)

Krótki: -0.36 (neutral)

Signal:(59.175) Neutral

Werewolf Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
RMRM	0.939
APOP	0.918
FEYE	0.897
SVOK	0.88
TLGT	0.879
SVAC	0.874
GAINL	0.874
PAIC	0.861
SYBX	0.854
TDAC	0.851

10 Najbardziej negatywne korelacje
MMAC	-0.959
AMRB	-0.922
BOCH	-0.893
NETE	-0.888
RGP	-0.851
SBBP	-0.823
SHSP	-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Werewolf Therapeutics, Korelacja - Waluta/Towar

0.85
( strong )

0.86
( strong )

0.00
( neutral )

0.88
( strong )

0.58
( weak )

-0.81
( strong negative )

Werewolf Therapeutics, Finanse

Annual	2023
Przychody:	$19.94M
Zysk brutto:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2023
Przychody:	$19.94M
Zysk brutto:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2022
Przychody:	$16.40M
Zysk brutto:	$13.89M (84.70 %)
EPS:	$-1.790

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-5.57

Financial Reports:

No articles found.

Werewolf Therapeutics,

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.